The differing interests of clinical and basic science researchers are apparent in the work of the finalists for Young Investigator Awards at this year’s ISMRM/ESMRMB meeting.
The differing interests of clinical and basic science researchers are apparent in the work of the finalists for Young Investigator Awards at this year's ISMRM/ESMRMB meeting.
The three finalists for the Moore Award for clinical research focused on cardiovascular topics, while two of the three finalists for the Rabi Award for basic research examined the high-powered potential of undersampled image reconstruction. The third candidate addressed questions about organ-specific effects of oxygen and carbogen that are relevant for applications in oncology, neuroradiology, and cardiac imaging.
The finalists' collective work reflects the breadth of science undertaken by the MRI community as whole, according to Dr. Daniel Sodickson, Young Investigator Award committee chair.
"It is a microcosm of the range of things that you will see at the meeting," said Sodickson, director of the Laboratory for Biomedical Imaging Research at Beth Israel Deaconess Medical Center in Boston.
The finalists for the two awards are presenting their papers throughout the week. The following are vying for the Moore Award:
Finalists for the Rabi Award are:
Twenty-five researchers submitted abstracts. Works were judged on the basis of novelty, innovation, and potential impact on MRI practice and science, Sodickson said. The judges also looked for young investigators who were the primary movers behind the project, not just team members. Winners will be announced on Thursday, May 24.
For more information, visit Diagnostic Imaging's ISMRM 2007 webcast
For additional coverage on these topics, examine the Diagnostic Imaging archives:
3D ultrasound speeds up monitoring of abdominal aortic aneurysms
Hyperpolarized gas MRI illuminates lung function
Parallel imaging spurs performance of MT at 3T
Report from ECR: Functional MR imaging maps brain function and plasticity
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.